U.S. market Closed. Opens in 11 hours 35 minutes

RPHM | Reneo Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue525.00K529.00K50.00K37.00K34.00K
Gross Profit-525.00K-529.00K-50.00K-37.00K-34.00K
Operating Expenses82.55M53.85M39.82M19.55M15.47M
Selling, General & Admin26.46M16.14M11.65M3.61M2.38M
Research & Development56.09M37.70M28.17M15.94M13.10M
Other Operating ExpensesN/A1.89M48.00K87.00K3.04M
Operating Income-83.08M-53.85M-39.82M-19.55M-15.47M
Other Expenses / Income5.69M1.89M48.00K87.00K3.04M
Before Tax Income-77.39M-51.95M-39.77M-19.46M-12.44M
Income Tax ExpensesN/A-1.89M-186.56K-169.30K-137.86K
Net Income-77.39M-50.06M-39.77M-19.46M-12.44M
Interest ExpensesN/A-1.89MN/AN/AN/A
Basic Shares Outstanding30.68M24.50M18.14M24.21M7.79M
Diluted Shares Outstanding30.68M24.50M18.14M24.21M7.79M
EBITDA-82.55M-53.76M-39.77M-19.52M-15.44M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-77.39M-53.85M-39.96M-19.63M-12.57M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙